Cargando…
Improvement of Erdheim-Chester disease-related renal failure after treatment with anakinra
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by infiltrates of lipid-laden CD68(+)/CD1a(−) histiocytes, affecting heart, lungs, central nervous system, and bones. Kidney and adjacent structures can also be affected, leading to renal failure in about 30% of...
Autores principales: | Podestà, Manuel Alfredo, Graziani, Giorgio, Reggiani, Francesco, Buemi, Michele, Badalamenti, Salvatore, Ponticelli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714171/ https://www.ncbi.nlm.nih.gov/pubmed/26877969 http://dx.doi.org/10.1016/j.krcp.2014.07.007 |
Ejemplares similares
-
Erdheim–Chester disease: from palliative care to targeted treatment
por: Graziani, Giorgio, et al.
Publicado: (2014) -
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib
por: Portegys, Jan, et al.
Publicado: (2023) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
Rare case of acute renal failure secondary to Erdheim-Chester disease
por: Makary, Joshua, et al.
Publicado: (2022) -
Unusual manifestation of Erdheim-Chester disease
por: Pan, Antony, et al.
Publicado: (2011)